Managing Immune Checkpoint Inhibitor Pneumonitis in the ICU
Recent advancements in the management of non-small cell lung cancer, especially with immunotherapeutic agents like immune checkpoint inhibitors (ICIs), have improved patient outcomes significantly. However, despite their effectiveness, ICIs can cause immune-related adverse events, including checkpoi...
Saved in:
| Main Authors: | Kristina Montemayor, MD, MHS, Mohammad I. Ghanbar, MD, Abigail L. Koch, MD, MHS, Karthik Suresh, MD, Robert Scott Stephens, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | CHEST Critical Care |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949788424000807 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclosporine successfully treats steroid-resistant checkpoint inhibitor-related pneumonitis: a case report
by: Jiaxi Deng, et al.
Published: (2024-11-01) -
Predictive value of machine learning for radiation pneumonitis and checkpoint inhibitor pneumonitis in lung cancer patients: a systematic review and meta-analysis
by: Shenghan Wang, et al.
Published: (2025-07-01) -
A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
by: Melina Yerolatsite, et al.
Published: (2025-04-01) -
Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis
by: Michelle Ploch, et al.
Published: (2025-01-01) -
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01)